Go for IOP Control From the Start VYZULTA should generally not be used in patients with active intraocular inflammation Macular edema, including cystoid macular edema, has been reported during treatment with prostaglandin analogs Use with caution in aphakic patients, in pseudophakic patients with a torn posterior lens capsule, or in patients with known risk factors for macular
Go for Monotherapy With the Only PGA That Delivers Nitric Oxide VYZULTA should generally not be used in patients with active intraocular inflammation Macular edema, including cystoid macular edema, has been reported during treatment with prostaglandin analogs Use with caution in aphakic patients, in pseudophakic patients with a torn posterior lens capsule, or in patients with known risk factors for macular
Product Monograph Template - Standard - vyzulta. ca If overdosage with VYZULTA® occurs, treatment should be symptomatic For management of a suspected drug overdose, particularly accidental oral ingestion, contact your regional poison control centre 5
Vyzulta (Bausch Lomb Incorporated): FDA Package Insert Bausch Lomb Incorporated: VYZULTA (latanoprostene bunod ophthalmic solution) 0 024% is indicated for the reduction of intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension
YOUR GUIDE TO TREATMENT WITH - vyzulta VYZULTA® may also cause your eyelashes to appear thicker and longer than they usually do and increase in number Eyelash changes are reversible after treatment with VYZULTA® is stopped
207795Orig1s000 - Food and Drug Administration Patients should also be informed of the possibility of eyelash and vellus hair changes in the treated eye during treatment with VYZULTA These changes may result in a disparity between eyes in length, thickness, pigmentation, number of eyelashes or vellus hairs, and or direction of eyelash growth
This label may not be the latest approved by FDA. For current . . . 5 4 Macular Edema Macular edema, including cystoid macular edema, has been reported during treatment with prostaglandin analogs VYZULTA should be used with caution in aphakic patients, in pseudophakic patients with a torn posterior lens capsule, or in patients with known risk factors for macular edema